Öz
Peripartum cardiomyopathy is a rare but significant condition occurring during late pregnancy or early postpartum period. Risk factors of peripartum cardiomyopathy include pregnancy, advanced maternal age, multiple pregnancies, and preeclampsia. This case report presented a case of a 32-year-old woman who developed an acute left bundle branch block due to peripartum cardiomyopathy during pregnancy. This case underscores the importance of considering peripartum cardiomyopathy in pregnant patients presenting with cardiac symptoms, especially those with risk factors such as advanced maternal age and multiple pregnancies. Prompt diagnosis and management are crucial to mitigate maternal and fetal risks associated with peripartum cardiomyopathy. Preeclampsia can lead to the development of peripartum cardiomyopathy, a rare but severe condition. Accurate diagnosis and appropriate treatment are essential. Clinicians should consider peripartum cardiomyopathy in patients presenting with preeclampsia symptoms.
Anahtar Kelimeler
Peripartum cardiomyopathy Pregnancy Acute left bundle branch block Preeclampsia Twin pregnancy
Kaynakça
- Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(2):207-21.
- Ijaz SH, Jamal S, Minhas AMK, Sheikh AB, Nazir S, Khan MS, et al. Trends in characteristics and outcomes of peripartum cardiomyopathy hospitalizations in the United States between 2004 and 2018. Am J Cardiol. 2022;168:142-50.
- Hoes MF, Arany Z, Bauersachs J, Hilfiker-Kleiner D, Petrie MC, Sliwa K, et al. Pathophysiology and risk factors of peripartum cardiomyopathy. Nat Rev Cardiol. 2022;19(8):555-65.
- Karaye KM, Ishaq NA, Sa'idu H, Balarabe SA, Talle MA, Isa MS, et al. Registry investigators. Incidence, clinical characteristics, and risk factors of peripartum cardiomyopathy in Nigeria: results from the PEACE Registry. ESC Heart Fail. 2020;7(1):235-43.
- Iorgoveanu C, Zaghloul A, Ashwath M. Peripartum cardiomyopathy: a review. Heart Fail Rev. 2021;26(6):1287-96.
- Jha N, Jha AK. Peripartum cardiomyopathy. Heart Fail Rev. 2021;26(4):781-97.
- Gorog DA, Vilahur G. Peripartum cardiomyopathy: can the link between prolactin and PAI-1 provide a clue? Cardiovasc Res. 2020;116(11):1791-3.
- Tanner MS, Davey MA, Mol BW, Rolnik DL. The evolution of the diagnostic criteria of preeclampsia-eclampsia. Am J Obstet Gynecol. 2022;226(2S):835-43.
- Keukens A, van Wely M, van der Meulen C, Mochtar MH. Pre-eclampsia in pregnancies resulting from oocyte donation, natural conception or IVF: a systematic review and meta-analysis. Hum Reprod. 2022;37(3):586-99.
- Laksono S, Prawara AS, Halomoan R. Diagnosis and management of severe peripartum cardiomyopathy. Indones J Obstet Gynecol. 2021;9(4):215-8.
- Davis MB, Jarvie J, Gambahaya E, Lindenfeld J, Kao D. Risk prediction for peripartum cardiomyopathy in delivering mothers: a validated risk model: PPCM risk prediction model. J Card Fail. 2021;27(2):159-67.
Öz
Peripartum kardiyomiyopati, gebeliğin sonlarında veya doğum sonrası erken dönemde ortaya çıkan nadir fakat önemli bir durumdur. Peripartum kardiyomiyopatinin risk faktörleri arasında gebelik, ileri anne yaşı, çoğul gebelikler ve preeklampsi bulunur. Bu vaka raporunda gebelik sırasında peripartum kardiyomiyopatiye bağlı olarak akut sol dal bloğu gelişen 32 yaşındaki kadın hasta sunulmaktadır. Bu vaka, kardiyak semptomlarla başvuran, özellikle de ileri anne yaşı ve çoğul gebelik gibi risk faktörleri olan gebe hastalarda peripartum kardiyomiyopatinin dikkate alınmasının önemini vurgulamaktadır. Hızlı teşhis ve tedavi, peripartum kardiyomiyopati ile ilişkili anne ve fetüs risklerini azaltmak için çok önemlidir. Preeklampsi, nadir fakat ciddi bir durum olan peripartum kardiyomiyopatinin gelişmesine yol açabilir. Doğru tanı ve uygun tedavi önemlidir. Klinisyenler preeklampsi semptomlarıyla başvuran hastalarda peripartum kardiyomiyopatiyi düşünmelidir.
Anahtar Kelimeler
Peripartum kardiyomiyopati Gebelik Akut sol dal bloğu Preeklampsi İkiz gebelik
Kaynakça
- Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(2):207-21.
- Ijaz SH, Jamal S, Minhas AMK, Sheikh AB, Nazir S, Khan MS, et al. Trends in characteristics and outcomes of peripartum cardiomyopathy hospitalizations in the United States between 2004 and 2018. Am J Cardiol. 2022;168:142-50.
- Hoes MF, Arany Z, Bauersachs J, Hilfiker-Kleiner D, Petrie MC, Sliwa K, et al. Pathophysiology and risk factors of peripartum cardiomyopathy. Nat Rev Cardiol. 2022;19(8):555-65.
- Karaye KM, Ishaq NA, Sa'idu H, Balarabe SA, Talle MA, Isa MS, et al. Registry investigators. Incidence, clinical characteristics, and risk factors of peripartum cardiomyopathy in Nigeria: results from the PEACE Registry. ESC Heart Fail. 2020;7(1):235-43.
- Iorgoveanu C, Zaghloul A, Ashwath M. Peripartum cardiomyopathy: a review. Heart Fail Rev. 2021;26(6):1287-96.
- Jha N, Jha AK. Peripartum cardiomyopathy. Heart Fail Rev. 2021;26(4):781-97.
- Gorog DA, Vilahur G. Peripartum cardiomyopathy: can the link between prolactin and PAI-1 provide a clue? Cardiovasc Res. 2020;116(11):1791-3.
- Tanner MS, Davey MA, Mol BW, Rolnik DL. The evolution of the diagnostic criteria of preeclampsia-eclampsia. Am J Obstet Gynecol. 2022;226(2S):835-43.
- Keukens A, van Wely M, van der Meulen C, Mochtar MH. Pre-eclampsia in pregnancies resulting from oocyte donation, natural conception or IVF: a systematic review and meta-analysis. Hum Reprod. 2022;37(3):586-99.
- Laksono S, Prawara AS, Halomoan R. Diagnosis and management of severe peripartum cardiomyopathy. Indones J Obstet Gynecol. 2021;9(4):215-8.
- Davis MB, Jarvie J, Gambahaya E, Lindenfeld J, Kao D. Risk prediction for peripartum cardiomyopathy in delivering mothers: a validated risk model: PPCM risk prediction model. J Card Fail. 2021;27(2):159-67.
Ayrıntılar
| Birincil Dil | İngilizce |
|---|---|
| Konular | Kardiyoloji , Kadın Hastalıkları ve Doğum |
| Bölüm | Olgu Sunumu |
| Yazarlar | |
| Erken Görünüm Tarihi | 8 Kasım 2024 |
| Yayımlanma Tarihi | 30 Aralık 2024 |
| Gönderilme Tarihi | 19 Mayıs 2024 |
| Kabul Tarihi | 1 Eylül 2024 |
| Yayımlandığı Sayı | Yıl 2024 Cilt: 26 Sayı: 3 |
Kaynak Göster
Duzce Medical Journal is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.